![[MMV]](IMG/img_top.jpg)
![[MMV]](IMG/espace_top.gif)
![[MMV]](IMG/logo_top.jpg){kind=logo}
 |
   Print Email this page Glossary |
Medicines for Malaria Venture (MMV)
Medicines for Malaria Venture (MMV) is a non-profit organization created to discover, develop and deliver effective and affordable antimalarial drugs through public-private partnerships.
Our vision is a world in which these innovative medicines will cure and protect the millions at risk of malaria and help to ultimately eradicate this terrible disease.
- MMV 7th Call for Letters of Interest
Now Open: MMV 7th Call for Letters of Interest Medicines for Malaria Venture is a not-for-profit...
> Read
- MMV welcomes two new colleagues to the team
The new year begins with two new additions to MMV: Dr Ambrose Talisuna to the Access and Delivery...
> Read
- Deutschsprachige MMV Mitteilungen - Dez. 2008
MMV information sheet for German policy makers The second edition of MMV's German newsletter will...
> Read
- MMV to collaborate with GSK on development of Tafenoquine for P.Vivax malaria
11 December 2008 - MMV has executed an agreement with GlaxoSmithKline (GSK) to develop tafenoquine...
> Read
- MMV at ASTMH 2008
MMV was involved in a number of sessions at the ASTMH in New Orleans. Presentations from the...
> Read
- MMV team: Patrick Nef joins as Executive Vice-President, Business Development
MMV is pleased to announce the appointment of a new member to its management team: Patrick Nef...
> Read
- StopMalariaNow! calls upon European governments to prioritise malaria control
StopMalariaNow!, a European advocacy group of which MMV is a member, has sent a letter to the...
> Read
- New technologies gearing up to meet rising demand for antimalarials
19 November 2008 A new report launched at a special meeting of the All Party Parliamentary Group...
> Read
